2. Epidemiology
Worldwide:
Eight million (3million children) new cases
each
Three million(1.3million children) deaths
year
95% occurs in developing countries with
high HIV/AIDS, limited diagnostic and
therapeutic facilities
3. Latent TB infection(LTBI)-occurs after
inhalation of infected droplet nuclei with
M.TB
This stage is characterized by:
Reactive Tuberculin skin test
Absence of clinical and
Radiological evidence of active
4. TB(Disease)- apparent signs/symptoms or
radiologic changes of active TB
Untreated infants with LTBI have 40%
liklihood of developing disease compared
with only 5-10% in adults
The greatest risk of progression occurs
during the 1st 2yr after infection
5. Risk for progression to TB from LTBI
increases in:
Infants & children below 5yrs of age
(especially <2yrs)
Co-infected with HIV
Persons with skin conversion in the past
1-2yr
Immunocompromization (malignancy,
drugs, DM, malnutrition)
6. Key risk factors for TB:
Strong contact with newly
diagnosed smear +ve case
Age below 5yrs
HIV infection
Severe malnutrition
7. The global burden of TB is increasing
due to:
oHIV epidemics
oPoverty
oCrowding
oInefficient TB control programs
oInadequate health coverage & poor
access to health services
9. M. tuberculosis
• Most important cause
• Non-spore forming
• Non-motile
• Obligate aerobe
• Slow-growing
• Grow best at 37-41o
C
• Cell wall with high lipid content which gives “acid-fast”
staining properties (resistance to decolorization with
acid alcohol)
10. Transmission and pathogenesis
Incubation period from infection to
development of +ve tuberculin test is 2-
6wks
Transmission is person to person
(usually by air borne mucus droplet
nuclei)
11. Risk of transmission is dependent on
:
Index case
Smear positive TB
Extensive upper lobe infiltrate &
cavity
Copious production of sputum
12. Environment:
• Poor ventilation
• Overcrowding
• Intimacy
Young children (<7yrs) rarely infect
others b/c:
• Sparse bacilli
• Cough is often absent or lacks the
tussive force to suspend infectious
particles of correct size
13. Immunity
Cell-mediated immunity develops 2-12wk after
infection, along with tissue hypersensitivity
After inhalation into the alveolus, bacillus is
ingested by macrophages but may not be killed
Alveolar macrophages present the antigen to T-
lymphocytes, producing DTH, which together with
newly activated macrophages causes IC killing of
bacilli & granuloma formation
Bacilli multiply, from granulomas, spread to local
LNs, & disseminate to extrathoraxic organs
lymphohematogenously.
14. The pathologic events in the initial
tuberculous infection depend on the balance
between:
Mycobacterial antigen load
Cell-mediated immunity(enhance IC killing)
Tissue hypersensitivity(promotes extracellular
killing)
When Ag load is small & tissue
hypersensitivity is high:
15. When both (Ag & sensitivity) are high:
• granuloma is less organized
• Tissue necrosis is incomplete
• Results in formation of caseous
material
When degree of tissue sensitivity is low
(infants, low immunity)
• Diffuse reaction
• Infection is not well contained
16. Factors that predispose to serious
disease:
• Young age
• Genetic factors
• Immunosuppression (AIDS,
malnutrition, measles, pertussis,
malignancy, steroids)
17. Tuberculin skin test
0.1ml of PPD, volar surface of arms
T-cells sensitized by prior infection are
recruited to the skin; release lymphokines
that induce indurations through local
vasodilatation, edema, fibrin deposition and
recruitment of other inflammatory cells to the
area
Amount of induration is measured 48-72hrs
18. Positive test:
> 10mm (immunocompetent) if
<5 = -ve, if b/n 5 -10 infection
by other weak type or prior
BCG vaccine
> 5mm (immunocompromised)
19. • False positive result:
• BCG
• 50% never develop the reaction
• Reactivity usually wanes in 2-3yrs
• If > 10mm , it is taken as +ve
• BCG is not a contraindication to PPD
test
21. Pathogenesis
The 1o complex of TB includes local infection at
the portal of entry (Ghon Focus) & regional LNs
Lung is portal of entry in more than 98% of cases
Bacilli multiply initially within alveoli & alveolar
ducts
Most are killed, some survive within inactivated
macrophages
Macrophages carry the bacilli to regional LNs by
lymphatic vessels
If lung is portal of entry, hilar LNs are often
22. Tissue reaction in the lung parenchyma & LNs
intensifies over the next 2-12wks
The parenchymal lesion of 1o complex often heals
completely by fibrosis or calcification
Occasionally may continue to enlarge & result in focal
pneumonitis & pleuritis
If caseation is intense, center of the lesion liquefies &
empties into the bronchus leaving a residual cavity
The infection of regional LNS develop some fibrosis &
encapsulation, but healing is usually incomplete
Viable M.TB can persist for decades within
parenchymal or LN foci
23. If hilar & Para tracheal LNs enlarge(as part of
host inflammatory reaction), they may ecroach
on a regional LN and bronchus (partial
obstruction bronchus)
distal hyperinflation and complete obstruction
results in atelectasis
Inflamed caseous nodes can attach to the
bronchial wall & erode through it, causing
endobronchial TB or a fistula tract
During the development of 1o complex, bacilli are
24. • Bacterial replication occurs in organs with
conditions that favor their growth:
• Lung apices
• Brain
• Kidneys
• Bones
• Disseminated TB occurs if:
• Circulating number of bacilli is large and
• Host immune response is inadequate
25. The time b/n initial infection & clinically apparent disease is
variable:
Disseminated & meningeal TB are early manifestations
(2-6mo after infection)
TB LAP & endobronchial TB(3-9mo)
Bones & joints take several years
Renal TB takes decades after infection
Pulmonary TB that occurs more than a year after 1o
infection is usually due to endogenous regrowth of bacilli
persisting in partially encapsulated lesions
Common site of reactivation is the apex of upper
lobes(oxygen & blood flow good)
26. Clinical manifestations
Primary Pulmonary Disease
70% of lung foci are subpleural & localized
pleurisy is common
All lobar segments of the lung are at equal
risk of initial infection
Enlarged LNs_ atelectasis
Subcarinal LAP may cause esophageal
compression & rarely
bronchoesophageal
May have lobar pneumonia without
impressive hilar LAP
27. Erosion of a parenchymal lesion into blood or lymphatic
vessel may result in dissemination of bacilli & a military
pattern (small nodules distributed on CXR)
Signs and symptoms of Primary Pulmonary Disease:
Surprisingly minimal out of proportion of X-ray findings
More than 50% with moderate to severe CXR findings
have no physical signs
Infants are more likely to experience S/Sx
Systemic (fever, night sweat, anorexia, decreased activity)
Failure to thrive
If bronchial obstruction, localized wheezes or decreased
breath sounds
In young children (<3yr), milliary TB may occur
28. Dx of primary pulmonary TB:
Most specific is isolation of M.TB
• Sputum (>7yr) for AFB stainig &
culture
• Early morning gastric aspirate (young
age)
Yield is low (25-50% positive with
3cultures)
Negative culture never exclude
pulmonary TB
If PPD is reactive, abnormal CXR &
contact Hx, adequate evidence
30. Progressive primary pulmonary
TB
Occurs when the primary infection is
not contained & produces
bronchopneumonia or lobar pneumonia
(usually middle, lower) & cavitations
High grade fever, severe cough with
sputum, weight, night sweats
Reduced breath sounds, rales,
dullness over the cavity
TST is reactive
31. Reactivation pulmonary TB
Rare in children
Most frequent site are the original parenchymal
focus, LNS or the apical segments (Simon foci)
established during the hematogenous phase of
early infection
Usually there is little/no LAP & no extrathoracic TB
b/c of the established immune response
preventing spread
S/Sx: related with cavitation & endobronchial
spread
Fever, night sweat, malaise, weight loss
Productive cough, heomptysis
32. Milliary TB
Wide spread hematogenous dissemination
with infection of multiple organs
Diagnosed when > 2organs are involved
Commonly involved organs are: lungs, liver,
spleen & BM
Lesions are of roughly same size as that of a
millet seed
Development of disseminated TB depends
on:
Number of bacilli released from primary focus
33. S/Sx:
Fever, weakness, malaise, anorexia,
weight loss, LAP,
night sweats & Hepatosplenomegally
Diffuse bilateral pneumonitis &
meningitis may be noted
Anemia, monocytosis,
thrombocytopenia & abnormal LFT are
common
TST is positive in only 60% of cases
Liver & BM Biopsy may be needed for
34. Extrapulmonary Tuberculosis (EPTB)
Every organ can be affected by tuberculosis
Common forms of extra pulmonary TB in children:
TB Lymphadenitis
• TB of Superficial LNs (Scrofula) is most common
form of EPTB
• Tonsilar, anterior cervical, submandibular &
supraclavicular nodes are involved secondary to
extension of lesions of upper lung lobes &
abdomen
• Inguinal, epitrochlear or axillary are associated
with skin or bone TB
35. Diseaes is usually unilateral
Initially firm, discrete, non-tender, multiple nodes
involved and mass of matted nodes will be formed
Systemic symptoms (except fever) are rare
TST is usually reactive
CXR is normal in 70% of cases
If untreated
• May resolve spontaneously
• Progress to caseation & necrosis (common)
Capsule will be ruptured & spread to adjacent
nodes
Rupture usually results in draning sinus tract
36. Dx of Tb lymphadenitis is biopsy.
Culture yield is 50%
Pleural Disease
• TB effusion can be localized or generalized
• Usually is a hypersensitivity response to TB
antigens
• May result from discharge of bacilli into the
pleural space from a subpleural pul. Focus
or caseated LN
37. Asymptomatic local pleural effusion is so frequent in
primary TB which is basically a component of the
primary complex
Large effusions occur months to yrs after primary
infection
TB effusion is infrequent in children below 6yrs
Usually unilateral
Rare in disseminated TB
Radiologic finding is more extensive than physical
findings
38. TST is positive in 70-80% of cases
Scoliosis is one of the complications
Prognosis is excellent
Pleural fluid & membrane examination
Pleural tap (Thoracentesis)
• Fluid is usually yellow (sometimes tinged with
blood)
• Sp.gr is 1.02-1.025
• Glucose is low
• AFB is rarely positive
• Culture is positive only in 30%
39. CNS TB
Most serious complication of dissemination (fatal
if no Rx)
TB meningitis
Usually arises from the formation of a metastatic
caseous lesions (cerebral cortex or meninges)
that develop during the lymphohematogenous of
primary infection
Initial lesion enlarges & discharges small no. of
bacilli into suabarachnoid space
The resulting gelatinous exudate infiltrates
corticomeningeal vessels
inflammation & obstruction (cerebral cortex
infarction)
40. The exudate also interferes with the CSF flow in &
out of the ventricle (at the level of basilar cisterns)_
Communicating hydrocephalus
The combination of vasculitis, infarction,
cerebral edema, and hydrocephalus results in
severe damage (gradual, rapid)
Electrolyte abnormalities (abnormal
metabolism, SIADH) also contributes to the
pathogenesis of TB meningitis
Most common b/n 6mo-4yrs
41. Clinical features
Rapid or slowly progressing
Mostly slow progression having 3
stages;
Stage I (1-2wks):
Non-specific symptoms (fever,
headache, irritability, malaise)
Focal neurologic deficits are rare
Stagnation or loss of developmental
milestones
43. Stage III:
Coma
Hemi-or para-plegia
Hyperetension
Decerebration
Deterioration of vital signs
Prognosis is dependent on stage of TB
meningitis
Stage I_ almost all survive without sequelae
Stage II_10-20% mortality and sequelae
Stage III_ 50% mortality and almost all remain
with sequelae
44. Common permanent disabilities:
Blindness
Deafness
Paraplegia
Diabetes Insipides
Mental retardation
Prognosis is worse in infants
45. Dx: high degree of suspicion
TST is positive in 50%
CXR is normal in 20-50%
CSF ANALYSIS
• WBC(10-500/mm3)
• Increased protein (400-5,000mg/dl)
• Glucose is usually < 40mg/dl
• AFB & culture yield is dependent on volume of
CSF
CT/MRI of the brain
46. Tuberculoma
Presents as brain tumor
In children most common infratentorially (base of
the brain near the cerebellum)
Lesions are most often singular
S/Sx:
headache, seizure, fever
TST is usually reactive
CXR is usually normal
Dx: CT/MRI- discrete lesions with significant
surrounding edema and ring enhancement
47. Perinatal TB
Can be congenital
Commonly acquired postnatal
Clinically
similar to sepsis & other neonatal
problems
May manifest early but common time
is 2-3wks of age (respiratory distress,
poor feeding, fever,
hepatosplenomegally, FTT, abdominal
distension)
48. • Dx and Mx of Perinatal TB
If mother has active TB:
Screen the newborn (S/Sx, gastric aspirate,
CXR)
If positive,antiTB
If negative,INH for 3months
At 3months, PPD
o if +ve, continue for 6-9mon
o If non-reactive, give BCG and DIC INH
Isolation of the newborn:
Seriously sick mother
Previous Rx for TB
Suspected drug resistant TB
49. Diagnosis of TB in children
Acid Fast Staining/culture (sputum, gastric
aspirate, LN, fluid) is definitive
Smear +ve TB:
The criteria are:
1. Two or more initial sputum smear examinations positive
for AFB; or
2. One sputum smear examination positive for AFB plus
CXR abnormalities consistent with active pulmonary TB,
as determined by a clinician; or
3. One sputum smear examination positive for AFB plus
sputum culture positive for M. tuberculosis.
50. Smear -ve TB:
Pulmonary TB, sputum smear negative
A case of pulmonary TB that does not meet the
definition for smear positive pulmonary TB;
Such cases include :
cases without smear results, which should be
exceptional in adults but relatively more
frequent in children.
51. Diagnostic criteria for sputum smear negative pulmonary
TB should include:
1. At least three sputum specimens negative for acid fast
bacilli; and
2. Radiological abnormalities consistent with active
pulmonary TB; and
3. No response to a course of broad spectrum antibiotics;
and
4. Decision by a clinician to treat with a full course of anti-
TB chemotherapy
52. If AFB is negative, Dx is based on:
Contact with patient(adult) with pulmonary
TB
S/Sx suggestive of TB
X-Ray finding consistent with TB
Positive TST
If 3 are fullfilled, TB is likely Dx
If severe malnutrition or immunosuppression,
2 criteria are enough
53. Management of childhood TB
Principles :
Chemotherapy/Anti-TB drugs
Nutritional rehabilitation
Screening of the family(index
case, other contacts)
Follow up (Adherence, response,
drug side effect)
54. Anti-TB drugs
The main objectives of anti-TB treatment are to:
1. Cure the patient (by rapidly eliminating most of the
bacilli);
2. Prevent death from active TB or its late effects;
3. Prevent relapse of TB (by eliminating the dormant
bacilli);
4. Prevent the development of drug resistance (by
using a combination of drugs);
5. Decrease TB transmission to others